Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. HSIC
stocks logo

HSIC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
3.35B
+4.9%
1.294
+8.76%
3.31B
+4.61%
1.270
+10.41%
3.35B
+3.43%
1.222
+11.08%
Estimates Revision
The market is revising Upward the revenue expectations for Henry Schein, Inc. (HSIC) for FY2025, with the revenue forecasts being adjusted by 0.61% over the past three months. During the same period, the stock price has changed by 5.63%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.61%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.72%
In Past 3 Month
Stock Price
Go Up
up Image
+5.63%
In Past 3 Month
Wall Street analysts forecast HSIC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is 75.78 USD with a low forecast of 58.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast HSIC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is 75.78 USD with a low forecast of 58.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
3 Hold
2 Sell
Moderate Buy
Current: 73.340
sliders
Low
58.00
Averages
75.78
High
90.00
Current: 73.340
sliders
Low
58.00
Averages
75.78
High
90.00
JPMorgan
NULL -> Overweight
maintain
$76 -> $78
2025-11-05
Reason
JPMorgan
Price Target
$76 -> $78
2025-11-05
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Henry Schein to $78 from $76 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report.
Barrington
NULL
to
Outperform
maintain
$78 -> $79
2025-11-05
Reason
Barrington
Price Target
$78 -> $79
2025-11-05
maintain
NULL
to
Outperform
Reason
Barrington raised the firm's price target on Henry Schein to $79 from $78 and keeps an Outperform rating on the shares. The company reported a strong Q3 and upped its 2025 outlook, the analyst tells investors in a research note.
Evercore ISI
Outperform
maintain
$83 -> $90
2025-11-05
Reason
Evercore ISI
Price Target
$83 -> $90
2025-11-05
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Henry Schein to $90 from $83 and keeps an Outperform rating on the shares. The dental market is stabilizing and operational improvements are underway, while the anticipation of a new CEO announcement in Q4 adds to the momentum, the analyst tells investors.
Leerink
Michael Cherny
Market Perform
maintain
$71 -> $75
2025-11-04
Reason
Leerink
Michael Cherny
Price Target
$71 -> $75
2025-11-04
maintain
Market Perform
Reason
Leerink analyst Michael Cherny raised the firm's price target on Henry Schein to $75 from $71 and keeps a Market Perform rating on the shares. A "clean beat" in Q3 is driving "a deserved stock price uptick," but the firm still struggles "to give a rational for why the stock should break out to the upside from what's been a fairly defined range," the analyst tells investors in a post-earnings note.
Evercore ISI
In Line -> Outperform
upgrade
$83
2025-08-26
Reason
Evercore ISI
Price Target
$83
2025-08-26
upgrade
In Line -> Outperform
Reason
Evercore ISI upgraded Henry Schein to Outperform from In Line with an $83 price target. The firm sees the company's earnings growth improving from automation, a new global e-commerce platform, salesforce efficiency, and better mix. Evercore's work indicates up to 400 basis point of operating margin expansion for Henry Schein, driving at least $7 of earnings per share in 2027. Consensus estimates for the company have upside, the analyst tells investors in a research note.
Barrington
Outperform
to
NULL
downgrade
$86 -> $78
2025-08-06
Reason
Barrington
Price Target
$86 -> $78
2025-08-06
downgrade
Outperform
to
NULL
Reason
Barrington lowered the firm's price target on Henry Schein to $78 from $86 and keeps an Outperform rating on the shares following the company's Q2 EPS shortfall. Despite what the firm calls a "somewhat disappointing quarter," it notes that management affirmed its previous FY25 guidance.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Henry Schein Inc (HSIC.O) is 14.06, compared to its 5-year average forward P/E of 15.62. For a more detailed relative valuation and DCF analysis to assess Henry Schein Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
15.62
Current PE
14.06
Overvalued PE
17.43
Undervalued PE
13.82

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
11.80
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.58
Undervalued EV/EBITDA
11.01

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.77
Current PS
0.00
Overvalued PS
0.87
Undervalued PS
0.67
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

HSIC News & Events

Events Timeline

(ET)
2025-12-01
16:50:00
Henry Schein Expands Exclusive Agreement with vVARDIS for Curodont Repair Fluoride Plus
select
2025-11-04 (ET)
2025-11-04
09:55:01
Significant Early Gainers in Liquid Options on November 4th
select
2025-11-04
06:02:12
Henry Schein increases FY25 adjusted EPS forecast to a range of $4.88-$4.96, up from $4.80-$4.94
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
12-02NASDAQ.COM
HSIC Stock Gains from Enhanced Collaboration with vVARDIS

  • Expansion of Distribution Rights: Henry Schein, Inc. has secured exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus product, effective January 1, 2026, which is expected to enhance its Dental business and support stock momentum.

  • Market Growth and Health Impact: The global dental caries treatment market is projected to grow significantly, driven by the rising prevalence of dental diseases and the introduction of innovative treatment options like Curodont, which addresses early-stage cavities without traditional drilling.

  • Strategic Partnerships: The company has also formed a strategic partnership with Oral Genome to distribute advanced salivary testing nationwide, further expanding its service offerings in the dental sector.

  • Stock Performance and Rankings: Henry Schein's shares have seen a slight increase, and the company holds a Zacks Rank #3 (Hold), while other medical stocks like Globus Medical and Boston Scientific are performing better in the market.

[object Object]
Preview
7.5
12-02Newsfilter
Henry Schein Secures Exclusive U.S. Distribution for Curodont™ Repair Fluoride Plus Across All Dental Segments by 2026
  • Market Expansion: Henry Schein's expanded agreement with vVARDIS grants exclusive U.S. distribution rights for Curodont™ Repair Fluoride Plus across all dental segments starting January 1, 2026, significantly enhancing market share across general dentistry, orthodontics, and pediatric dentistry.
  • Innovative Product: Curodont™ is a drill-free, needle-free solution for treating early-stage cavities, expected to address the untreated cavity issue affecting up to 80% of patients, thereby improving overall oral health and reducing the risk of related diseases.
  • Success Metrics: vVARDIS reports that Curodont™ has been accessed by over 10% of U.S. dental offices and has treated more than 500,000 patients, demonstrating strong demand and growth potential in the market.
  • Strategic Partnership: This expanded collaboration not only solidifies Henry Schein's leadership position in the U.S. dental market but also reflects a shared commitment to enhancing dental professionals' efficiency and improving community health outcomes.
[object Object]
Preview
5.0
12-01NASDAQ.COM
HSIC Shares Poised to Gain from Launch of Henry Schein One's Workflow

  • AI Integration in Dental Software: Henry Schein One has introduced AI and automation workflows, including Voice Notes, at the 2025 Greater New York Dental Meeting, enhancing practice efficiency and revenue management through better claims processing and patient communication.

  • Partnership with AWS: The company has partnered with Amazon Web Services to integrate generative AI technologies across its platforms, aiming to improve the overall dental experience from patient intake to treatment planning.

  • Market Performance and Growth: Despite a recent 1.2% drop in shares, Henry Schein's stock has seen a 15.4% increase over the past month, with projected earnings growth of 3.6% for 2025, supported by strong sales and operational improvements.

  • Innovative Features for Practices: New features like the Forms workflow and Detect AI enhance patient data accuracy and diagnostic confidence, while multilingual support and real-time transcription reduce administrative burdens, allowing dental teams to focus more on patient care.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Henry Schein Inc (HSIC) stock price today?

The current price of HSIC is 73.34 USD — it has increased 0.63 % in the last trading day.

arrow icon

What is Henry Schein Inc (HSIC)'s business?

Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

arrow icon

What is the price predicton of HSIC Stock?

Wall Street analysts forecast HSIC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is 75.78 USD with a low forecast of 58.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Henry Schein Inc (HSIC)'s revenue for the last quarter?

Henry Schein Inc revenue for the last quarter amounts to 3.34B USD, increased 5.20 % YoY.

arrow icon

What is Henry Schein Inc (HSIC)'s earnings per share (EPS) for the last quarter?

Henry Schein Inc. EPS for the last quarter amounts to 0.83 USD, increased 6.41 % YoY.

arrow icon

What changes have occurred in the market's expectations for Henry Schein Inc (HSIC)'s fundamentals?

The market is revising Upward the revenue expectations for Henry Schein, Inc. (HSIC) for FY2025, with the revenue forecasts being adjusted by 0.61% over the past three months. During the same period, the stock price has changed by 5.63%.
arrow icon

How many employees does Henry Schein Inc (HSIC). have?

Henry Schein Inc (HSIC) has 25000 emplpoyees as of December 05 2025.

arrow icon

What is Henry Schein Inc (HSIC) market cap?

Today HSIC has the market capitalization of 8.63B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free